KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Share-based Compensation (2017 - 2025)

Guardant Health (GH) has disclosed Share-based Compensation for 9 consecutive years, with $43.2 million as the latest value for Q4 2025.

  • Quarterly Share-based Compensation rose 18.76% to $43.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $166.2 million through Dec 2025, up 18.38% year-over-year, with the annual reading at $166.2 million for FY2025, 18.38% up from the prior year.
  • Share-based Compensation hit $43.2 million in Q4 2025 for Guardant Health, up from $42.8 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $55.1 million in Q1 2021 to a low of $20.6 million in Q3 2022.
  • Historically, Share-based Compensation has averaged $32.2 million across 5 years, with a median of $27.1 million in 2024.
  • Biggest five-year swings in Share-based Compensation: surged 768.87% in 2021 and later plummeted 54.97% in 2022.
  • Year by year, Share-based Compensation stood at $26.9 million in 2021, then dropped by 11.74% to $23.7 million in 2022, then increased by 2.6% to $24.3 million in 2023, then skyrocketed by 49.53% to $36.4 million in 2024, then increased by 18.76% to $43.2 million in 2025.
  • Business Quant data shows Share-based Compensation for GH at $43.2 million in Q4 2025, $42.8 million in Q3 2025, and $42.5 million in Q2 2025.